Foot problems in diabetes: an overview.

Diabetes is the leading cause of nontraumatic lower-extremity amputations in the United States. Most amputations are preceded by an ulcer, and ulcers are costly in their own right. Most ulcers are neuropathic in etiology and plantar in location. They occur typically at sites of high mechanical loading because of repetitive trauma in people with loss of pain sensation. In an adequately perfused limb, such ulcers are not difficult to heal. When they are properly mechanically off-loaded, approximately 90% of these wounds heal in approximately 6 weeks. The reference standard off-loading device is the total contact cast, but other reasonably efficacious methods exist. Screening and implementation of preventive measures in the high-risk patient are highly recommended and can reduce the incidence of ulceration. All patients with diabetes should be screened annually for loss of protective sensation, with the 10-g Semmes-Weinstein monofilament being the easiest tool to use. Education to prevent complications should be implemented for all patients with loss of protective sensation.

[1]  W. Jeffcoate,et al.  Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Pinget,et al.  Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. , 2003, Diabetes care.

[3]  Benjamin A Lipsky Medical treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. Chantelau Therapeutic footwear in patients with diabetes. , 2002, JAMA.

[5]  P. Haage,et al.  An Audit of Cushioned Diabetic Footwear: Relation to Patient Compliance , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[6]  P. Helm,et al.  Recurrence of neuropathic ulceration following healing in a total contact cast. , 1991, Archives of physical medicine and rehabilitation.

[7]  W. Zamboni,et al.  Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. , 1997, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[8]  W. D. Fishco Surgically induced Charcot's foot. , 2001, Journal of the American Podiatric Medical Association.

[9]  P. Scuffham,et al.  The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. , 2003 .

[10]  D. Margolis,et al.  Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. , 1999, Diabetes care.

[11]  C. Agardh,et al.  Long‐term prognosis for diabetic patients with foot ulcers , 1993, Journal of internal medicine.

[12]  A. Morabito,et al.  Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study , 1996, Diabetes Care.

[13]  M. Tsang,et al.  Human epidermal growth factor enhances healing of diabetic foot ulcers. , 2003, Diabetes care.

[14]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[15]  P. Scuffham,et al.  The health care costs of diabetic peripheral neuropathy in the US. , 2003, Diabetes care.

[16]  G. Gibbons Lower extremity bypass in patients with diabetic foot ulcers. , 2003, The Surgical clinics of North America.

[17]  J. Apelqvist,et al.  Health-economic consequences of diabetic foot lesions. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Armstrong,et al.  Therapeutic footwear in patients with diabetes [2] (multiple letters) , 2002 .

[19]  David G Armstrong,et al.  It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. Boulton,et al.  The Association Between Callus Formation, High Pressures and Neuropathy in Diabetic Foot Ulceration , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[21]  G. Reiber,et al.  Pathways to Diabetic Limb Amputation: Basis for Prevention , 1990, Diabetes Care.

[22]  F. Logerfo,et al.  Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. , 1984, The New England journal of medicine.

[23]  K. Harding,et al.  Diagnosing foot infection in diabetes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  H Gin,et al.  Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. , 2002, Diabetes & metabolism.

[25]  Anthony Delitto,et al.  Total Contact Casting in Treatment of Diabetic Plantar Ulcers: Controlled Clinical Trial , 1989, Diabetes Care.

[26]  D. Steed Foundations of good ulcer care. , 1998, American journal of surgery.

[27]  Patrick J Heagerty,et al.  Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. , 2002, JAMA.

[28]  W. Marston,et al.  The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. , 2003, Diabetes care.

[29]  P. Cavanagh,et al.  The Role of Cultures in Mild Diabetic Foot Cellulitis , 2000 .

[30]  P. Cavanagh,et al.  Elevated Plantar Pressure and Ulceration in Diabetic Patients After Panmetatarsal Head Resection: Two Case Reports , 1999, Foot & ankle international.

[31]  C. Attinger,et al.  Lengthening the Achilles tendon for the treatment of diabetic plantar forefoot ulceration. , 2003, The Surgical clinics of North America.

[32]  P. Cavanagh,et al.  What the Practising Physician Should Know about Diabetic Foot Biomechanics , 2002 .

[33]  E. Masson,et al.  The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[34]  Andrew J.M. Boulton,et al.  The Foot in diabetes , 2000 .

[35]  Y. Mercke,et al.  Resection of the metatarsal head for diabetic foot ulcers. , 1998, American journal of surgery.

[36]  D. Sinacore,et al.  Total contact casting for diabetic neuropathic ulcers. , 1996, Physical therapy.

[37]  T. Daniels,et al.  Midfoot and hindfoot arthrodeses in diabetic Charcot arthropathy. , 2000, Canadian journal of surgery. Journal canadien de chirurgie.

[38]  D. Armstrong,et al.  Off-loading the diabetic foot wound: a randomized clinical trial. , 2001, Diabetes care.

[39]  G. Reiber,et al.  Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. , 2001, Diabetes care.

[40]  James C. Wang Use of external fixation in the reconstruction of the Charcot foot and ankle. , 2003, Clinics in podiatric medicine and surgery.

[41]  D. Armstrong,et al.  Therapeutic footwear in patients with diabetes. , 2002, JAMA.

[42]  Stone Nc,et al.  Midfoot and hindfoot arthrodeses in diabetic Charcot arthropathy. , 2000 .

[43]  E. Chantelau,et al.  Antibiotic Treatment for Uncomplicated Neuropathic Forefoot Ulcers in Diabetes: a Controlled Trial , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[44]  Robert B. Anderson,et al.  Dorsiflexion Metatarsal Osteotomy for Treatment of Recalcitrant Diabetic Neuropathic Ulcers , 1999, Foot & ankle international.

[45]  W. Rathmann,et al.  How should peripheral neuropathy be assessed in people with diabetes in primary care? A population‐based comparison of four measures , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[46]  David G Armstrong,et al.  Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. , 2001, Diabetes care.

[47]  L. Uccioli,et al.  Manufactured Shoes in the Prevention of Diabetic Foot Ulcers , 1995, Diabetes Care.

[48]  E. Chantelau,et al.  Effectiveness of a new brand of stock ‘diabetic’ shoes to protect against diabetic foot ulcer relapse. A prospective cohort study , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[49]  G. Reiber,et al.  The burden of diabetic foot ulcers. , 1998, American journal of surgery.

[50]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[51]  A. Sampson,et al.  A meta-analytic approach to an integrated summary of efficacy: a case study of becaplermin gel. , 2002, Controlled clinical trials.

[52]  Benjamin A Lipsky,et al.  Diagnosis and treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  E. A. Nelson,et al.  Dressings and topical agents for arterial leg ulcers. , 2003, The Cochrane database of systematic reviews.